Form 4 for MDGL MADRIGAL PHARMACEUTICALS, INC.
Accepted 2024-06-27 00:00:00 ET · period of report 2024-06-25 · accession 0000950170-24-078749 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-06-27 | 2024-06-25 | MDGL | Levy Richard S | Dir | A - Grant | $0.00 | +714 | 11.0K | +7% | $0 |
| D | 2024-06-27 | 2024-06-25 | MDGL | Levy Richard S | Dir | A - Grant | $0.00 | +1,105 | 1,105 | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-06-25 | A | A | 714 | $0.00 | 11,012 | D | — | — | (F1) Represents a grant of restricted stock units, which vest on June 25, 2025, provided the Reporting Person continues in service with the Issuer on such date. |
| 2 | Derivative | Stock Option (Right to Buy) | 2024-06-25 | A | A | 1,105 | $0.00 | 1,105 | D | $280.04 · — to 2031-06-25 | 1,105 Common Stock | (F2) The option vests as to 100% of underlying shares on the first anniversary of the grant date, provided that the Reporting Person continues to serve as a director of the Issuer until such anniversary date. |